|
|
|
|
Kathleen Clouse
Director, Division of Monoclonal Antibodies, CDER
FDA
 Dimiter S Dimitriov
Head & Senior Investigator, Protein Interaction Group
National Institutes of Health
 Janice M Reichert
Senior Research Fellow/Editor-in-Chief
Tufts Center for the Study of Drug Development/mAbs
Patrick Liu
Associate Director, Development Sciences
Genentech
 Juan Carlos Almagro
Research Fellow, Head, Antibody Design Group
Centocor
|
|
|
|
|
Terrapinn's 5th annual antibody and antibody alternative event launches US version
This is a pivotal time for the future of antibody and antibody alternative development. Our understanding of monoclonal antibodies and antibody alternatives has grown
enormously, resulting in more product launches, greater competition and enhanced potential to treat patients.
Americas Antibody Congress is THE forum for senior-level executives in the biotech & pharmaceutical industries to gather together to discuss this soon-to-be $30 billion industry.
» Reserve your seat now and save $840
» Download the post event report to learn about the 2009 conference
Key topics
- The pharmaceutical industry landscape
- Identifying antibody targets
- Non-activating antibody formats
- Strategies to minimize immunogenicity
- De novo selection of high affinity antibodies
- Tailoring antibodies to enhance target site distribution
- Enhancing effector function
- Bi-specific antibodies
- Antibody drug conjugate development
- Next generation biologics
- Regulatory & approval process updates for monoclonal antibodies and biologics
- Follow on and second generation biologics
» Book now before prices increase
» Request more information
|
|
|
» Request the 2010 brochure
|
Americas Antibody Congress will focus on issues in regulation and clinical trials, determining immunogenicity, successfully identifying lead candidates, advancing your knowledge of optimal production and manufacturing, developing next-generation antibody products and identifying the future therapeutic targets for antibody development.
Americas Antibody Congress is an interactive platform where innovations are discussed, best practices are shared, and partnership opportunities are sealed.
» Find out how you could benefit
» Register today for maximum savings
|
6 reasons why you can't afford to miss this event:
Seniority
Our speaker faculty and audience consist of the industry’s most respected scientists and pharma
executives.
Quality of content
The content has been created and developed by the biologics industry for the biologics industry.
There are no sales pitches.
More than 35 speakers confirmed so far
A truly diverse line-up covering discovery, development and commercialization.
A proven track record
Terrapinn’s strong global portfolio of life science events.
Identify actionable investment opportunities
Put the foundation in place and establish the relationships necessary to bring your product to
the marketplace.
New business
With more competition than ever before, there is no better place to meet new clients and partners and generate new leads for your business.
» Reserve your seat now and save $840!
» Request more information
» Find out how you could benefit
» Reserve your seat now for your best price
|
|
|
|
|
|
|
|
|
|
